Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Cancer|May 24, 2019
Nonadherent behaviors among young women on adjuvant endocrine therapy for breast cancerJohanna Wassermann, Shari I Gelber, Shoshana M Rosenberg, et al.
Thyroid : Official Journal of the American Thyroid Association|July 26, 2022
Possible Primary Thyroid Nuclear Protein in Testis Carcinomas with <i>NSD3::NUTM1</i> Translocation Revealed by RNA Sequencing: A Report of Two CasesNoémie Scherman, Johanna Wassermann, Camille Tlemsani, et al.
Bulletin Du Cancer|October 1, 2021
[Molecular genotyping in refractory thyroid cancers in 2021: When, how and why? A review from the TUTHYREF network]Christelle de la Fouchardière, Johanna Wassermann, Fabien Calcagno, et al.
Breast Cancer Research and Treatment|November 27, 2022
Adjuvant endocrine therapy non-initiation and non-persistence in young women with early-stage breast cancerShoshana M Rosenberg, Yue Zheng, Shari Gelber, et al.
Cancer Medicine|August 29, 2025
Vinorelbine With or Without Thiotepa for HER2-Negative Metastatic Breast Cancer: A Propensity Score AnalysisAurelia Robert, Paul Gougis, Elise Dumas, et al.
Annales D'Endocrinologie|May 9, 2025
ENDOCAN TUTHYREF network consensus recommendations: Refractory follicular-derived thyroid cancerChristine Do Cao, Yann Godbert, Stéphane Bardet, et al.
Acta Oncologica (Stockholm, Sweden)|June 5, 2023
FOLFIRI in advanced platinum-resistant/refractory small-cell lung cancer: a retrospective studyCyril Roussel-Simonin, Paul Gougis, Donia Lassoued, et al.
Cancer Medicine|November 1, 2023
Impact of the COVID-19 pandemic on clinical presentation, treatments, and outcomes of new breast cancer patients: A retrospective multicenter cohort studyEtienne Guével, Sonia Priou, Guillaume Lamé, et al.
European Journal of Cancer (Oxford, England : 1990)|September 12, 2021
Intermittent versus continuous administration of pazopanib in progressive radioiodine refractory thyroid carcinoma: Final results of the randomised, multicenter, open-label phase II trial PAZOTHYRChristelle de la Fouchardière, Yann Godbert, Cécile Dalban, et al.
Plos Medicine|December 24, 2019
Association of body mass index and cardiotoxicity related to anthracyclines and trastuzumab in early breast cancer: French CANTO cohort studyElisé G Kaboré, Charles Guenancia, Ines Vaz-Luis, et al.
Pageof 3